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Unit of Respiratory Medicine, Department of Medicine, Royal Infirmary, Lauriston Place, 
Edinburgh EH3 gYW, Scotland, U.K. 
Survival in patients with hypoxic chronic obstructive pulmonary disease (COPD) is improved by 
long-term oxygen therapy (LTOT). Such patients are known to desaturate during activity and at night. 
The aim of this study was to assess the adequacy of oxygenation in patients with COPD receiving LTOT. 
Oxygen saturation (SaO,) was measured at home over 24 h in 20 patients with hypoxic COPD 
receiving LTOT. Eleven had arterial oxygen partial pressure values (PaO,) 2 8 kPa (Group 1) and nine 
had PaO, ~8 kPa (Group 2) at rest, breathing oxygen. There was no difference in SaO, during the day 
and night when breathing oxygen. In Group 1, SaO, was >90% for 78 + 24% of the 24-h period. Four 
patients spent between 75 and 90%, and three spent ~75% of the 24-h period with SaO, >90%. In Group 
2, SaO, was ~90% for 69 * 27% of the 24-h period (P=O.O2). Two patients spent between 75 and 90%, 
and four spent ~7.5% of the 24-h period with SaO, >90%. Measurements of SaO, over 24 h in patients 
with hypoxic COPD, while breathing oxygen, add further information to arterial blood gas sampling on 
the adequacy of oxygenation, and reveal inadequate oxygenation in many patients. 
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Introduction 
Long-term oxygen therapy (LTOT) improves 
survival in patients with hypoxic chronic 
obstructive pulmonary disease (COPD) (1,2). In 
the U.K., the prescription criteria include a 
forced expiratory volume in 1 s (FEV,) <: 1.5 1 
and PaO, ~7.3 kPa at rest, when clinically stable 
and receiving optimal therapy (3); those who 
continue to smoke should be excluded, and it is 
recommended that patients receive oxygen at 
least 15 h daily (3). When breathing oxygen, the 
PaO, should be above 8 kPa (4) because survival 
in patients with hypoxic COPD receiving LTOT 
is related to PaO, (5). Patients with COPD are 
known to desaturate during exercise (6) and 
during sleep, particularly rapid eye movement 
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(REM) sleep (7). Hypoxaemia in such patients 
is associated with cardiac arrhythmias (8) and 
pulmonary hypertension (9), and survival relates 
to both the mean and lowest nocturnal SaO, 
during sleep (10). In view of the relationship 
between PaO, and survival, the aim of this study 
was to assess oxygen saturation (,SaO,) while 
breathing oxygen in patients with COPD who 
had been prescribed LTOT, to determine the 
adequacy of their oxygenation. In addition, the 
authors wished to determine whether the use of 
portable oximeters, to monitor SaO, over 24 h, 
provided important additional information to 
random blood gas measurements in the assess- 
ment of oxygenation in such patients. 
Methods 
PATIENTS 
Sixty-five patients with hypoxic COPD receive 
LTOT in the authors’ clinic. Patients suspected 
of having co-existent obstructive sleep apnoea 
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on the basis of a history of snoring and excessive 
daytime sleepiness are referred for sleep studies 
and are not included in this group. Thirty-six 
had a follow-up arterial blood gas measurement 
while breathing oxygen from a concentrator at 
their prescribed flow rate (l-3 1 min - ‘). In this 
group, 75% had an adequate PaO, breathing 
oxygen (PaO, 28 kPa). From these 36 patients, 
20 (12 males and eight females) were randomly 
selected to determine whether non-invasive 
measurements of oxygen saturation would add 
further information about the adequacy of their 
oxygenation. Eleven were well oxygenated while 
breathing oxygen from the concentrator with 
PaO, 28 kPa (Group 1); nine of the group did 
not achieve this level (Group 2). There was no 
significant difference in the length of time each 
group had received LTOT before study [Group 
1: 14.9 f 11.9 (SD), Group 2: 16.0 f 18.2 
months]. 
STUDY DESIGN 
Oxygen was delivered from DeVilbiss concentra- 
tors, Mini DeVo, model 4442, which were main- 
tained regularly and produced >92% oxygen at 
flow rates up to 3 1 min - ‘. PaO, was checked 
while the patient rested, sitting in the clinic after 
receiving the prescribed flow rate of oxygen for 
30 min. Oxygen saturation was measured at 
home during normal daily activities, and patients 
were asked to continue breathing oxygen for all 
of the 24-h study period. Sufficient oxygen was 
provided to allow patients to move freely around 
their homes whilst receiving oxygen. SaO, was 
measured with a Minolta Pulsox 7 portable 
oximeter and probe securely attached to the 
patient’s finger for two consecutive periods of 
12 h covering the day and night. The record was 
retrieved after each 12-h period by one of the 
investigators. The oximeter could be powered 
either by mains electricity or battery. In 32 
patients randomly selected from the clinic, SaO, 
was compared with PaO, measured from an 
arterial blood gas sample taken simultaneously. 
STATISTICS 
Values are given as mean f SD. Differences in 
mean values were analysed by a paired Student’s 
t-test for comparison of day and night, and 
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FIG. 1. The correlation between simultaneous 
measurements of SaO, by pulse oximeter and 
derived from arterial blood gas measurements in 32 
patients with COPD. rz0.93, P<O-001, n=32. 
TABLE 1. Patient characteristics 
Age 68 & 5 (years) 
FEV, 0.6 f 0.2 (1) 
FVC 1.9 zt 0.7 (1) 
PaO, (breathing air) 6.4 & 0.8 (kPa) 
PaCO, 7.2 f 1.1 (kPa) 
H+ 41.6 f 3.8 (nmol l- ‘) 
PaO, (breathing 0,) 8.5 f l-2 (kPa) 
PaCO, 7.8 & 1.5 (kPa) 
H, 41.6 f 3.8 (nmol 1-l) 
an unpaired Student’s t-test for comparison 
between the patient groups. Correlation was 
performed by linear regression analysis. 
Results 
The correlation between SaO, measured by oxi- 
metry and derived from arterial blood gas values 
is shown in Fig. 1. The characteristics of the 
study patients are shown in Table 1. There 
was no difference in PaCO, between the well- 
oxygenated and poorly-oxygenated groups 
either breathing air (Group 1 7.07 f 1.39 kPa, 
Group 2 7.44 f 0.75 kPa) or oxygen (Group 1 
7.71 f 1.66 kPa, Group 2 8.05 f 1.28 kPa). 
In a comparison of daytime and nocturnal 
oxygen saturation for the two groups as a whole 
[n=20, Fig. 2(a)], SaO, was >90% for 72 f 30% 
of the time from 09.00-21.00 h and was >90% 
for 77 f 24% of the time from 21.00-09.00 h (not 
significant). SaO, was I 85% for 8.4 f 9.8% and 
6.3 f 7.3% of the respective periods. In Group 1 
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(n= 11, PaO, I 8 kPa breathing oxygen), SaO, 
was >90% for 78 f 24% of the 24-h period [Fig. 
2(b)]. Four of the 11 patients spent between 75 
and 90% of the 24-h period with SaO, >90% and 
three spent ~75% of this period with SaO, >90% 
[Fig. 2(c)]. In Group 2 (~1~9, PaO, ~8 kPa 
breathing oxygen), SaO, was >90% for only 
69 f 27% of the 24-h period (P=O-02). Two of 
the nine patients spent between 75 and 90% of 
the time with SaO, >90% and four spent <75% 
of the time with SaO, >90%. 
Discussion 
Over 24 h, in the 20 patients studied, oxygen 
saturation was above 90%, and thus could be 
considered as adequate, for only approximately 
three-quarters of the time, whilst breathing oxy- 
gen. There was no difference between day and 
night in the percentage of time spent with SaO, 
above 90%, confirming the results of Sliwinski et 
al. in their study of a mixed group of ‘pink 
puffers’ and ‘blue bloaters’ receiving LTOT. This 
was also true in both studies for periods when 
SaO, was below 90%. 
The present results showing that 11/20 
patients had a PO, 2 8 kPa breathing oxygen is 
comparable with the Swedish oxygen register 
where only 550/o of patients on LTOT had PaO, 
~8 kPa at three consecutive follow-ups and in 
50% it was <8 kPa on all three (11). It has been 
shown previously that the mean and lowest 
nocturnal PaO, can be predicted from the mean 
awake PaO, (10). Not surprisingly, therefore, 
significantly less time was spent above 90% in 
those patients who were not adequately oxygen- 
ated as measured by PaO, breathing oxygen. 
Four out of nine spent ~75% of the time above 
90%. However, even in those 11 patients who 
appeared to be well oxygenated in terms of 
PaO,, there were three patients who spent ~75% 
of the time above 90% saturation. Similar results 
were published by Carroll et al. (12) in 10 
patients with COPD treated with LTOT with 
PaO, >8 kPa breathing oxygen and SaO, 
2 90%. In this study, four patients spent between 
53 and 85% of the time with SaO, <90%, 
although two appeared to have coexistent 
upper airways obstruction. Thus, studying 
oxygen saturation in this group adds further 
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FIG. 2. (a) The percentage of time spent with SaO, 
>90”/0 during the day and night in all patients 
studied (n=20, Mean A SD). (b) The percentage of 
24 h spent with SaO, ~90% in Group 1 (>8 kPa, 
n=ll) and Group 2 (~8 kPa, ti=9), *P<O.O5. (c) 
The number of patients in Group 1 (>8 kPa) and 
Group 2 (~8 kPa) spending <75%, 75-90X and 
>90% of 24 h with SaO, >90%. Solid bars, <75%; 
stippled bars 75-90X; hatched bars >90%. 
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information to our knowledge of the adequacy 
of their oxygenation. 
Episodes of desaturation occur during the 
daytime, presumably during activity, although 
Sliwinski et al. (13) have shown that many in fact 
occur during daytime naps. At night, desatura- 
tion occurs during phasic REM sleep (7). These 
episodes may be overcome by increasing the flow 
rate of oxygen during daytime activities and 
sleep, although this may of course be at the 
expense of an elevation in PaCO*. Compliance 
with treatment in this study could not be con- 
trolled. Although the patients were asked to 
breath oxygen throughout the 24-h study period, 
one cannot exclude the possibility that nasal 
prongs were removed at times during the day or 
were displaced at night. It is not possible, there- 
fore, to know whether patients were insuffi- 
ciently treated for 22 and 31% of the time in the 
well-oxygenated and poorly-oxygenated groups 
due to physical exercise, sleep or poor com- 
pliance. However, it is clear that reliance cannot 
be put on a single arterial blood gas measure- 
ment to ensure the adequacy of oxygenation as 
even in a group which is apparently well oxygen- 
ated (PaO, 2 8 kPa breathing oxygen), only 78% 
of the time was spent with SaO, >90%, and 7/l 1 
patients in this group spent ~90% of the time 
with SaO, ~90% (and 3/11 ~75% of the time). 
Thus, oxygen saturation measurements over 24 h 
add further information to random blood gas 
measurements. 
Survival in patients with COPD relates to 
mean and lowest nocturnal SaO,, although 
excess nocturnal hypoxaemia does not alter 
prognosis (10). Survival is worse in those with 
COPD who desaturate at night (14). This may 
be related to increased pulmonary arterial pres- 
sure (9) and perhaps to cardiac arrhythmias 
which are increased during desaturation (8). 
In 100 hospitalized medical patients, a corre- 
lation between episodes of desaturation below 
90% and increased mortality was seen even 
though only 7.1% of the total monitoring period 
in these patients was spent with SaO, ~90% (15). 
In conclusion, continuous measurements of 
oxygen saturation in patients with hypoxic 
COPD breathing oxygen reveal inadequate 
oxygenation in many patients which may be the 
reason why survival is not improved in some 
patients who receive LTOT. 
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